Evaluation of the pro- and antioxidant status of women with HIV or coinfection


Cite item

Full Text

Abstract

Aim. To reveal the specific features of changes in the parameters of lipid peroxidation – antioxidant defense and the status of the reproductive system in women of fertile age with monoinfection (HIV) or coinfection (HIV and hepatitis B and/or C). Subjects and methods. 81 reproductive-aged women were examined and divided into 3 groups: 1) 28 apparently healthy women (controls); 2) 26 patients with HIV monoinfection; and 3) 27 patients with HIV coinfection (HIV + hepatitis B and/or C) who had not previously received antiretroviral therapy. Results. The HIV coinfection group showed the higher values of primary (conjugated dienes) and secondary (ketodienes and conjugated trienes) lipid peroxidation products in the presence of lower superoxide dismutase activity and obvious α-tocopherol deficiency than the control and HIV monoinfection groups. HIV coinfection in reproductive-aged women was accompanied by the high frequency of luteal phase deficiency. Conclusion. HIV coinfection is characterized by a more pronounced oxidative stress, antioxidant factor deficiency, and the high frequency of luteal phase deficiency in the patients.

References

  1. Соколова Е.В., Покровский В.В., Ладная Н.Н. Ситуация по ВИЧ-инфекции в Российской Федерации. Терапевтический архив. 2013;11:10-15.
  2. Potter M, Klein MB. Co-infections and co-therapies: treatment of HIV in the presence of hepatitis C and hepatitis B. HIV Therapy. 2009;3(2):189-207. doi: 10.2217/17584310.3.2.189
  3. Piroth L, Duong M, Quantin C, Abrahamowicz M, Michardiere R, Aho L-S, Grappin M, Buisson M, Waldner A, Portier H, Chavanet P. Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? AIDS. 1998;12(4):381-388. doi: 10.1097/00002030-199804000-00006
  4. Baecher-Lind LE, Miller WC, Wilcox AJ. Infectious disease and reproductive health: a review. Obstet Gynecol Survey. 2010;65(1):53-65. doi: 10.1097/ogx.0b013e3181c9e7a1
  5. Штейман А.А., Охапкин М.Б., Ершова Ю.В. Прогнозирование риска преждевременных родов у ВИЧ-инфицированных. Казанский медицинский журнал. 2015;96(2):182-186. doi: 10.17750/kmj2015-182
  6. Landes M, Newell ML, Barlow P. Hepatitis B or hepatitis C coinfection in HIV-infected pregnant women in Europe. HIV Med. 2008;9:526-534. doi: 10.1111/j.1468-1293.2008.00599.x
  7. Schieber M, Chandel NS. ROS Function in Redox Signaling and Oxidative Stress. Cur Biol. 2014;24(10):R453-R462. doi: 10.1016/j.cub.2014.03.034
  8. Луценко М.Т., Андриевская И.А., Ишутина Н.А. Кислородтранспортная функция крови у беременных, перенесших обострение герпес-вирусной инфекции. Вестник Российской академии медицинских наук. 2012;67(6):66. doi: 10.15690/vramn.v67i6.286
  9. Колесникова Л.И., Баирова Т.А., Первушина О.А. Гены ферментов антиоксидантной системы. Вестник Российской академии медицинских наук. 2013:68(12):83. doi: 10.15690/vramn.v68i12.865
  10. Kashou AH, Agarwal A. Oxidants and antioxidants in the pathogenesis of HIV/AIDS. The Open Reprod Sci J. 2011;3:154-161. doi: 10.2174/1874255601103010154
  11. Baum M, Sales S, Jayaweera D, Lai S, Bradwin G, Rafie C, Page J, Campa A. Coinfection with hepatitis C virus, oxidative stress and antioxidant status in HIV-positive drug users in Miami. HIV Med. 2011;12(2):78-86. doi: 10.1111/j.1468-1293.2010.00849.x
  12. Rajopadhye S, Marita A, Ansari M, Chowdhary A, Dandekar S. Assessment of oxidative stress parameters in HIV infection. BMC Infect Dis. 2014;14(3):E28. doi: 10.1186/1471-2334-14-s3-e28
  13. Lin W, Weinberg EM, Chung RT. Pathogenesis of Accelerated Fibrosis in HIV/HCV Co-infection. J Infect Dis. 2013;207(suppl.1):S13-S18. doi: 10.1093/infdis/jis926
  14. Stehbens WE. Oxidative stress in viral hepatitis and AIDS. Exper Mol Pathol. 2004;77(2):121-132. doi: 10.1016/j.yexmp.2004.04.007
  15. Kolesnikova LI, Darenskaya МА, Grebenkina LA, Labygina AV, Suturina LV, Dolgikh MI, Shiphineeva TI, Darzhaev ZYu, Tsyrenov TB, Rinchindorzhieva MP. Activity of lipid peroxidation in infertile women from different populations. Bull Exper Biol Med. 2012;154(2):203-205. doi: 10.1007/s10517-012-1912-4
  16. Paracha U, Fatima K, Alqahtani M, Chaudhary A, Abuzenadah A, Damanhouri G, Qadri I. Oxidative stress and hepatitis C virus. Virol J. 2013;10(1):251. doi: 10.1186/1743-422x-10-251
  17. Костюшов В.В., Бокал И.И., Петров С.А. Изучение активности ферментов антиоксидантной системы крови при ВИЧ-инфекции. Биомедицинская химия. 2010;56(5):596-601. doi: 10.18097/pbmc20105605596
  18. Mehta S, Spiegelman D, Aboud S, Giovannucci EL, Msamanga GI, Hertzmark E, Mugusi FM, Hunter DJ, Fawzi WW. Lipid-soluble vitamins A, D, and E in HIV-infected pregnant women in Tanzania. EurJ Clin Nutr. 2010;64(8):808-817. doi: 10.1038/ejcn.2010.76
  19. Harlow SD, Schuman P, Cohen M, Ohmit SE, Cu-Uvin S, Lin X, Anastos K, Burns D, Greenblatt R, Minkoff H, Muderspach L, Rompalo A, Warren D, Young MA, Klein RS. Effect of HIV Infection on Menstrual Cycle Length. J Acquired Immune Deficiency Syndromes. 2000;24(1):68-75. doi: 10.1097/00042560-200005010-00012
  20. Clark RA, Mulligan K, Stamenovic E, Chang B, Watts H, Andersen J, Squires K, Benson C. Frequency of Anovulation and Early Menopause among Women Enrolled in Selected Adult AIDS Clinical Trials Group Studies. J Infect Dis. 2001;184:1325-1327. doi: 10.1086/323999
  21. Massad LS, Evans CT, Minkoff H, Watts DH, Greenblatt RM, Levine AM, Anastos K, Young M, Seifer DB, Golub E, Cohen M. Effects of HIV Infection and Its Treatment on Self-Reported Menstrual Abnormalities in Women. J Women’s Health. 2006;15(5):591-598. doi: 10.1089/jwh.2006.15.591
  22. Agarwal A, Gupta S, Sharma R Oxidative stress and its implications in female infertility — a clinician’s perspective. Reprod Biomed Online. 2005;11(5):641-650. doi: 10.1016/S1472-6483(10)61174-1

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies